Regenerative capacity of mesenchymal stem cells in the management of Asherman syndrome – a systematic review and meta-analysis of clinical outcomes
Stem cell therapy is safe and effective in improving endometrial thickness, menstrual function and pregnancy rate in women with refractory AS. However, given the limitations of our study, further studies with a large sample size are needed to validate the findings.
Authors
- Vikas Chandra Jha (ORCID: https://orcid.org/0000-0002-0080-061X)
- Sharda Jha
- Sangam Jha (ORCID: https://orcid.org/0000-0002-4349-1589)
- Shalini Singh (ORCID: https://orcid.org/0000-0002-0652-4580)
- Pratap Kumar Patra (ORCID: https://orcid.org/0000-0002-0338-7517)
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Menopausal Review
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/pm.2025.157933
- Primary Topic
- Gynecological conditions and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00